Search company, investor...

Predict your next investment

Corporate Venture
FINANCE | Lending
orix.com/capital-solution/growth-capital

Investments

73

Portfolio Exits

39

Funds

1

Partners & Customers

2

About ORIX Growth Capital

ORIX Growth Capital is a provider of highly customized equity and debt solutions for high-growth companies.

Headquarters Location

1717 Main Street Suite 1100

Dallas, Texas, 75201,

United States

214-237-2000

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest ORIX Growth Capital News

DrChrono Raises $12M in Funding

Jun 30, 2021

DrChrono , a Sunnyvale CA-based company focused on platform and services for modern medical practices, raised $12M in funding. The round was led by ORIX Growth Capital. The company intends to use the funds to: expand the telehealth offerings on the DrChrono platform, grow operations and enhance across the other key product areas including EHR, practice management, medical billing and its core partner API. DrChrono provides a platform which offers EHR, practice management, medical billing, revenue cycle management, and API solutions. It is currently used by thousands of physicians and has over 28 million patients under the care of DrChrono providers. The company has facilitated millions of appointments and the processing of more than $11 billion of medical billing to date. FinSMEs

ORIX Growth Capital Investments

73 Investments

ORIX Growth Capital has made 73 investments. Their latest investment was in Lemnature AquaFarms as part of their Unattributed VC on May 5, 2023.

CBI Logo

ORIX Growth Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/4/2023

Unattributed VC

Lemnature AquaFarms

$7.83M

Yes

1

3/17/2022

Line of Credit

PolicyGenius

Yes

1

10/20/2021

Debt

VFP Pharmacy Group

$12M

Yes

3

6/23/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

1/13/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/4/2023

3/17/2022

10/20/2021

6/23/2021

1/13/2020

Round

Unattributed VC

Line of Credit

Debt

Series C

Series B

Company

Lemnature AquaFarms

PolicyGenius

VFP Pharmacy Group

Subscribe to see more

Subscribe to see more

Amount

$7.83M

$12M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

3

10

10

ORIX Growth Capital Portfolio Exits

39 Portfolio Exits

ORIX Growth Capital has 39 portfolio exits. Their latest portfolio exit was Alula on October 02, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/2/2023

Merger

$99M

2

4/25/2023

Acquired

$99M

13

3/2/2022

Acq - Fin

$99M

2

11/17/2021

Merger

Subscribe to see more

$99M

Subscribe to see more

10

11/2/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/2/2023

4/25/2023

3/2/2022

11/17/2021

11/2/2021

Exit

Merger

Acquired

Acq - Fin

Merger

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

13

2

10

10

ORIX Growth Capital Fund History

1 Fund History

ORIX Growth Capital has 1 fund, including ORIX Venture Finance LLC.

Closing Date

Fund

Fund Type

Status

Amount

Sources

ORIX Venture Finance LLC

Multi-Stage Venture Capital

Closed

1

Closing Date

Fund

ORIX Venture Finance LLC

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

Sources

1

ORIX Growth Capital Partners & Customers

2 Partners and customers

ORIX Growth Capital has 2 strategic partners and customers. ORIX Growth Capital recently partnered with ANA Holdings on November 11, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

11/11/2021

Partner

Japan

ANA HOLDINGS, ORIX Corporation and Hirata Gakuen Partner to conduct Urban Air Mobility Trials in Osaka.

A member of Star Alliance since 1999 , All Nippon Airways has joint venture agreements with United Airlines , Lufthansa German Airlines , Swiss International Airlines , Austrian Airlines and Brussels Airlines -- giving it a truly global presence .

1

11/15/2016

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

11/11/2021

11/15/2016

Type

Partner

Partner

Business Partner

Country

Japan

United States

News Snippet

ANA HOLDINGS, ORIX Corporation and Hirata Gakuen Partner to conduct Urban Air Mobility Trials in Osaka.

A member of Star Alliance since 1999 , All Nippon Airways has joint venture agreements with United Airlines , Lufthansa German Airlines , Swiss International Airlines , Austrian Airlines and Brussels Airlines -- giving it a truly global presence .

Subscribe to see more

Subscribe to see more

Sources

1

10

ORIX Growth Capital Team

6 Team Members

ORIX Growth Capital has 6 team members, including current Managing Director, William Bishop.

Name

Work History

Title

Status

William Bishop

Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

William Bishop

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Managing Director

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.